These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 229236)

  • 21. Presynaptic effects of bekanamycin at the frog neuromuscular junction. Reversibility by calcium and aminopyridines.
    Uchiyama T; Molgo J; Lemeignan M
    Eur J Pharmacol; 1981 Jul; 72(4):271-80. PubMed ID: 6268416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of calcium ions on bimodal parameters of mediator liberation in frog sartorius muscle neuromuscular junctions].
    Zefirov AL
    Fiziol Zh SSSR Im I M Sechenova; 1980 Apr; 66(4):531-6. PubMed ID: 6104608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effects of clindamycin and lincomycin on end-plate currents and quantal content at the neuromuscular junction.
    Fiekers JF; Henderson F; Marshall IG; Parsons RL
    J Pharmacol Exp Ther; 1983 Nov; 227(2):308-15. PubMed ID: 6313896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presynaptic effects of sodium bisulfite at the frog neuromuscular junction.
    Steinacker A
    J Neurosci Res; 1982; 7(3):313-9. PubMed ID: 6982346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in miniature endplate potential frequency during repetitive nerve stimulation in the presence of Ca2+, Ba2+, and Sr2+ at the frog neuromuscular junction.
    Zengel JE; Magleby KL
    J Gen Physiol; 1981 May; 77(5):503-29. PubMed ID: 6262429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The action of chlorpromazine at an isolated cholinergic synapse.
    Argov Z; Yaari Y
    Brain Res; 1979 Mar; 164():227-36. PubMed ID: 218686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maitotoxin activates quantal transmitter release at the neuromuscular junction: evidence for elevated intraterminal Ca2+ in the motor nerve terminal.
    Kim YI; Login IS; Yasumoto T
    Brain Res; 1985 Nov; 346(2):357-62. PubMed ID: 2996708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the ionophore X-537A on acetylcholine release at the frog neuromuscular junction.
    Kita H; Van Der Kloot W
    J Physiol; 1976 Jul; 259(1):177-98. PubMed ID: 182959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Miniature endplate potentials as a tool in neurotoxicology.
    Csicsaky M; Wiegand H; Uhlig S; Lohmann H; Papadopoulos R
    Toxicology; 1988 Apr; 49(1):121-9. PubMed ID: 2836968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The action of thallium acetate on phasic transmitter release in the mouse neuromuscular junction.
    Wiegand H; Lohmann H; Chandra SV
    Arch Toxicol; 1986 Apr; 58(4):265-70. PubMed ID: 2424403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dependence of spontaneous release at frog junctions on synaptic strength, external calcium and terminal length.
    Grinnell AD; Pawson PA
    J Physiol; 1989 Nov; 418():397-410. PubMed ID: 2576068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etomidate evokes synaptic vesicle exocytosis without increasing miniature endplate potentials frequency at the mice neuromuscular junction.
    Valadão PA; Naves LA; Gomez RS; Guatimosim C
    Neurochem Int; 2013 Nov; 63(6):576-82. PubMed ID: 24044896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The thiol-oxidizing agent diamide increases transmitter release by decreasing calcium requirements for neuromuscular transmission in the frog.
    Carlen PL; Kosower EM; Werman R
    Brain Res; 1976 Nov; 117(2):257-76. PubMed ID: 186154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of Ca(2+)-dependent and Ca(2+)-independent miniature endplate potentials by phorbol ester and adenosine in frog.
    Searl TJ; Silinsky EM
    Br J Pharmacol; 2005 Aug; 145(7):954-62. PubMed ID: 15880138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of 3,4-diaminopyridine on spontaneous and evoked transmitter release at the frog neuromuscular juction [proceedings].
    Durant NN; Marshall IG
    J Physiol; 1978 Jul; 280():21P. PubMed ID: 211226
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of lead on neuromuscular transmission in the frog.
    Manalis RS; Cooper GP; Pomeroy SL
    Brain Res; 1984 Feb; 294(1):95-109. PubMed ID: 6320979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in MEPP frequency during depression of evoked release at the frog neuromuscular junction.
    Zengel JE; Sosa MA
    J Physiol; 1994 Jun; 477(Pt 2):267-77. PubMed ID: 7932218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of 4-aminopyridine on neuromuscular transmission.
    Lundh H
    Brain Res; 1978 Sep; 153(2):307-18. PubMed ID: 210882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of lanthanum ions on the amplitude distributions of miniature endplate potentials and on synaptic vesicles in frog neuromuscular junctions.
    Kriebel ME; Florey E
    Neuroscience; 1983 Jul; 9(3):535-47. PubMed ID: 6312368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further comparison of the effects of physostigmine and neostigmine on frog neuromuscular transmission.
    Alderdice MT
    Clin Exp Pharmacol Physiol; 1982; 9(1):35-43. PubMed ID: 6284424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.